Earl PL - Search Results

1

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.

Barouch DH, Stephenson KE, Borducchi EN, Smith K, Stanley K, McNally AG, Liu J, Abbink P, Maxfield LF, Seaman MS, Dugast AS, Alter G, Ferguson M, Li W, Earl PL, Moss B, Giorgi EE, Szinger JJ, Eller LA, Billings EA, Rao M, Tovanabutra S, Sanders-Buell E, Weijtens M, Pau MG, Schuitemaker H, Robb ML, Kim JH, Korber BT, Michael NL. Barouch DH, et al. Among authors: earl pl. Cell. 2013 Oct 24;155(3):531-9. doi: 10.1016/j.cell.2013.09.061. Epub 2013 Oct 24. Cell. 2013. PMID: 24243013 Free PMC article.

2

Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.

Lieberman J, Fabry JA, Kuo MC, Earl P, Moss B, Skolnik PR. Lieberman J, et al. J Immunol. 1992 May 1;148(9):2738-47. J Immunol. 1992. PMID: 1374097

3

Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers.

Earl PL, Doms RW, Moss B. Earl PL, et al. J Virol. 1992 Sep;66(9):5610-4. doi: 10.1128/JVI.66.9.5610-5614.1992. J Virol. 1992. PMID: 1501294 Free PMC article.

4

Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Earl PL, Koenig S, Moss B. Earl PL, et al. J Virol. 1991 Jan;65(1):31-41. doi: 10.1128/JVI.65.1.31-41.1991. J Virol. 1991. PMID: 1985202 Free PMC article.

5

Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

Earl PL, Hügin AW, Moss B. Earl PL, et al. J Virol. 1990 May;64(5):2448-51. doi: 10.1128/JVI.64.5.2448-2451.1990. J Virol. 1990. PMID: 2182912 Free PMC article.

6

Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain.

Doms RW, Earl PL, Chakrabarti S, Moss B. Doms RW, et al. Among authors: earl pl. J Virol. 1990 Jul;64(7):3537-40. doi: 10.1128/JVI.64.7.3537-3540.1990. J Virol. 1990. PMID: 2352332 Free PMC article.

7

Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein.

Earl PL, Moss B. Earl PL, et al. AIDS Res Hum Retroviruses. 1993 Jul;9(7):589-94. doi: 10.1089/aid.1993.9.589. AIDS Res Hum Retroviruses. 1993. PMID: 8369163

8

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.

Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W, Berzofsky JA. Belyakov IM, et al. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1709-14. doi: 10.1073/pnas.95.4.1709. Proc Natl Acad Sci U S A. 1998. PMID: 9465081 Free PMC article.

9

Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.

Earl PL, Sugiura W, Montefiori DC, Broder CC, Lee SA, Wild C, Lifson J, Moss B. Earl PL, et al. J Virol. 2001 Jan;75(2):645-53. doi: 10.1128/JVI.75.2.645-653.2001. J Virol. 2001. PMID: 11134278 Free PMC article.

10

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, Miller J, McClure HM, McNicholl JM, Moss B, Robinson HL. Amara RR, et al. Among authors: earl pl. Science. 2001 Apr 6;292(5514):69-74. doi: 10.1126/science.1058915. Science. 2001. PMID: 11393868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page